[Federal Register Volume 79, Number 53 (Wednesday, March 19, 2014)]
[Pages 15360-15361]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-06049]



Advisory Committee on the Medical Uses of Isotopes: Call for 

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Call for nominations.


SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) is advertising 
for nominations for the position of Radiation Oncologist Physician 
(Brachytherapy) on the Advisory Committee on the Medical Uses of 
Isotopes (ACMUI). Nominees should be a currently practicing radiation 

DATES: Nominations are due on or before May 19, 2014.
    Nomination Process: Submit an electronic copy of resume or 
curriculum vitae, along with a cover letter and endorsement letter(s) 
from professional organizations, or others, to Ms. Sophie Holiday, 
[email protected]. The cover letter should describe the nominee's 
current duties and responsibilities and express the nominee's interest 
in the position. Please ensure that the resume or curriculum vitae 
includes the following information, if applicable: education; 
certification; professional association membership and committee 
membership activities; duties and responsibilities in current and 
previous clinical, research, and/or academic position(s).

Regulatory Commission, Office of Federal and State Materials and 
Environmental Management Programs; (301) 415-7865; 
[email protected].

[[Page 15361]]

SUPPLEMENTARY INFORMATION: The ACMUI brachytherapy radiation oncologist 
provides advice on issues associated with radiation oncology and the 
clinical use of brachytherapy, including the use of permanently 
implanted microspheres. This advice includes providing input on NRC 
proposed rules and guidance, providing recommendations on the training 
and experience requirements for physicians specializing in this use, 
identifying medical events associated with this use, evaluating non-
routine uses of byproduct material and emerging medical technologies, 
bringing key issues in the radiation oncology community to the 
attention of NRC staff, and other radiation oncology issues as they 
relate to radiation safety and NRC medical-use policy.
    ACMUI members are selected based on their educational background, 
certification(s), work experience, involvement and/or leadership in 
professional society activities, and other information obtained in 
letters or during the selection process.
    ACMUI members possess the medical and technical skills needed to 
address evolving issues. The current membership is comprised of the 
following professionals: (a) nuclear medicine physician; (b) nuclear 
cardiologist; (c) two radiation oncologists; (d) diagnostic 
radiologist; (e) therapy medical physicist; (f) nuclear medicine 
physicist; (g) nuclear pharmacist; (h) radiation safety officer; (i) 
patients' rights advocate; (i) Food and Drug Administration 
representative; and (j) Agreement State representative. For additional 
information about membership on the ACMUI, visit the ACMUI Membership 
Web page, http://www.nrc.gov/aboutnrc/regulatory/advisory/acmui/membership.html.
    NRC is inviting nominations for the Radiation Oncologist physician 
position on the ACMUI. The term of the individual currently occupying 
this position will end on February 25, 2015. Committee members 
currently serve a four-year term and may be considered for 
reappointment to an additional term.
    Nominees must be U.S. citizens and be able to devote approximately 
160 hours per year to Committee business. Members are expected to 
attend semi-annual meetings in Rockville, Maryland, and to participate 
in teleconferences, as needed. Members who are not Federal employees 
are compensated for their service. In addition, these members are 
reimbursed for travel and correspondence expenses. Full-time Federal 
employees are reimbursed travel expenses only.
    Security Background Check: The selected nominee will undergo a 
thorough security background check. Security paperwork may take the 
nominee several weeks to complete. Nominees will also be required to 
complete a financial disclosure statement to avoid conflicts of 

    Dated at Rockville, Maryland, this 13th day of March, 2014.

    For the U.S. Nuclear Regulatory Commission.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. 2014-06049 Filed 3-18-14; 8:45 am]